Several other equities research analysts have also commented on the company. JPMorgan Chase & Co. boosted their price objective on Victrex from GBX 2,250 ($31.55) to GBX 2,580 ($36.17) and gave the stock a neutral rating in a research note on Monday, January 8th. Barclays cut their price objective on Victrex from GBX 2,350 ($32.95) to GBX 2,270 ($31.83) and set an equal weight rating for the company in a research note on Tuesday, November 28th. Berenberg Bank reiterated a buy rating and set a GBX 2,600 ($36.46) price objective on shares of Victrex in a research note on Tuesday, December 5th. Peel Hunt lowered Victrex to a hold rating and set a GBX 2,300 ($32.25) price objective for the company. in a research note on Tuesday, October 31st. Finally, Deutsche Bank reiterated a hold rating and set a GBX 2,200 ($30.85) price objective on shares of Victrex in a research note on Thursday, January 4th. Eight equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock currently has an average rating of Hold and an average price target of GBX 2,319.80 ($32.53).
Victrex (LON:VCT) opened at GBX 2,446 ($34.30) on Monday. Victrex has a 1-year low of GBX 1,826 ($25.60) and a 1-year high of GBX 2,772 ($38.87). The company has a market cap of $2,100.00 and a PE ratio of 2,108.62.
In other news, insider Martin Court sold 441 shares of the company’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of GBX 2,618 ($36.71), for a total value of £11,545.38 ($16,188.14). Insiders bought 14 shares of company stock valued at $36,018 over the last 90 days.
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.